Metrizamide

This classification denotes a contrast agent with the molecular formula C18H22I3N3O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RHH3W8F1CO, chemically known as 3-acetylamino-5-n-methyl-acetylamino-2,4,6-triiodobenzoyl glucosamine but more generally known as metrizamide, which bears U.S. National Institutes of Health Compound Identifier 35734. The European Medicines Agency schedules Metrizamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08921MIG. The term METRIZAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 26, No. 10 1972, List 12). The World Health Organization schedules metrizamide in its Anatomical Therapeutic Chemical (ATC) Classification. METRIZAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Metrizamide under HS 29329970. SMILES: IC1C(C(=O)NC2C(O)C(O)C(OC2O)CO)C(I)C(NC(=O)C)C(I)C1N(C)C(=O)C.